Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Most Accessed Articles

Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?

, 2017; 4(2): 74-81.

Manon Launay, Joseph Ciccolini*, Anne Rodallec, Claire Fournel, Florence Duffaud, Sebastien Salas and Bruno Lacarelle


DOI: 10.2174/2212697X04666170531080625



Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World

, 2017; 4(2): 82-92.

Antonello Di Paolo*, Marzia Del Re, Elena Arrigoni, Teresa Di Desidero, Eleonora Rofi, Romano Danesi and Guido Bocci


DOI: 10.2174/2212697X04666170817124625





Prevention of Capecitabine Toxicity Using a 5-FU Test Dose

, 2017; 4(2): 112-121.

Teresa Di Desidero, Cecilia Barbara, Paola Orlandi, Anna Fioravanti, Fotios Loupakis, Chiara Cremolini, Giacomo Allegrini, Antonello Di Paolo, Alfredo Falcone, Romano Danesi and Guido Bocci*


DOI: 10.2174/2212697X04666170504144550







Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog